Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin and renal disease.

R D Emkey

    The American Journal of Medicine
    |June 14, 1983
    PubMed
    Summary

    Long-term aspirin use is unlikely to cause serious kidney disease, despite historical links to renal papillary necrosis. Studies show minimal renal dysfunction in patients with prolonged aspirin intake.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis.

    Calcified tissue international·2002
    Same author

    Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

    Arthritis and rheumatism·2001
    Same author

    Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Arthritis and rheumatism·1999
    Same author

    Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women.

    Clinical chemistry·1999
    Same author

    Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.

    The American journal of medicine·1996
    Same author

    The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis.

    Arthritis and rheumatism·1996

    Area of Science:

    • Nephrology
    • Pharmacology
    • Toxicology

    Background:

    • Historical data suggests a link between aspirin and renal papillary necrosis, often in analgesic mixtures.
    • The term "analgesic nephropathy" emerged, with phenacetin identified as a common factor in clinical studies.
    • Experimental data implicates aspirin as a primary nephrotoxin in rats, unlike phenacetin.

    Purpose of the Study:

    • To investigate the long-term effects of aspirin consumption on renal function.
    • To determine if continuous aspirin intake over a decade leads to significant renal dysfunction.
    • To clarify the role of aspirin in causing serious kidney disease.

    Main Methods:

    • Analysis of historical data and case reports on analgesic nephropathy.
    • Review of experimental studies in laboratory animals (rats) using aspirin and phenacetin.
    • Evaluation of renal function in 46 patients with continuous aspirin use for over 10 years.

    Main Results:

    • Rats fed aspirin alone developed renal papillary necrosis, while phenacetin required massive doses.
    • Acute aspirin use showed reversible renal function effects in lupus nephritis patients.
    • No significant renal dysfunction was observed in patients with long-term (≥10 years) aspirin use.

    Conclusions:

    • Aspirin may cause minor, reversible renal abnormalities.
    • Long-term salicylate consumption is unlikely to result in serious kidney disease.
    • The risk of analgesic nephropathy is more strongly associated with combination analgesics than aspirin alone.

    Related Experiment Videos